Ads

 

Ads

 

Ads

 

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

World Rank (Jan-05-2024)
144
Market Cap (Jan-05-2024)
100.011 Billion USD
World Rank (Jul-30-2023)
174
Market Cap (Jul-30-2023)
81.855 Billion USD
World Rank (Jan-07-2022)
279
Market Cap (Jan-07-2022)
64.927 Billion USD
World Rank (Jan-01-2021)
308
Market Cap (Jan-01-2021)
51.551 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 97
Headquarters Country
Nasdaq / NYSE Code
REGN
Market Cap (Mar-08-2026)
80.33
Employee Count
11,851
Employee Count as of Date
As on Dec-2022
Headquarters City/State
World Region
World Subregion
Annual Revenue in USD
13,117 Million USD
Annual Operating Income in USD
4,233 Million USD
Annual Net Income in USD
3,953 Million USD
Annual Results for Period Ending
Dec-2023 ending year
Total Assets in USD
33,080 Million USD
Total Liabilities in USD
7,107 Million USD
Total Equity in USD
25,973 Million USD
Balance Sheet for Period Ending
Dec-2023 ending year

Share

Ads